Table 3 Correlation of the RHI with soluble biomarkers
| Â | RHI | |
|---|---|---|
r, p value* | n | |
ME/CFS | ||
ET-1 (pg/ml) | − 0.108, p = 0.716 | 14 |
Ang-2 (pg/ml) | − 0.174, p = 0.553 | 14 |
ACE activity (U/l) | − 0.083, p = 0.788 | 13 |
ACE2 (U/ml) | 0.503, p = 0.069 | 14 |
IL-8 post-erythrocyte lysis (pg/ml) | − 0.130, p = 0.659 | 14 |
PCS | ||
ET-1 (pg/ml) | 0.162, p = 0.549 | 16 |
Ang-2 (pg/ml) | − 0.165, p = 0.541 | 16 |
ACE activity (U/l) | − 0.041, p = 0.882 | 16 |
ACE2 (U/ml) | − 0.359, p = 0.173 | 16 |
IL-8 post-erythrocyte lysis (pg/ml) | − 0.057, p = 0.833 | 16 |
HC | ||
ET-1 (pg/ml) | − 0.179, p = 0.524 | 15 |
Ang-2 (pg/ml) | 0.125, p = 0.657 | 15 |
ACE2 (U/ml) | 0.386, p = 0.157 | 15 |